Diabetic retinopathy is a common side effect of diabetes and the leading cause of blindness in young adults in the Unite…
Research
Swedish Company, Diamyd Medical AB, Plans to Have Diabetes Vaccine by 2011
Diamyd Medical AB, a Swedish diabetes company focusing on the development of pharmaceuticals for the treatment of autoim…
Osiris Completes Enrollment in Stem Cell Trial for Type 1 Diabetes
Osiris Therapeutics, Inc. today announced that it has achieved a $750,000 milestone payment from the Juvenile Diabetes R…
FDA Clears Clibra’s Insulin Patch
Calibra Medical Inc., formerly known as Seattle Medical Technologies Inc., announced today that the U.S. Food and Drug A…
JDRF Announces Diabetes Research Program with Johnson & Johnson
The Juvenile Diabetes Research Foundation announced today in a press release that it will begin working with The Johnson…
FDA Approves Diamyd Vaccine Study In Children As Young As 3
Diamyd Medical, a Swedish diabetes company focusing on the development of pharmaceuticals for the treatment of autoimmun…
Diabetes UK to Fund New Diabetes Research
Diabetes UK announced that it would be dedicating almost £750,000 ($1,200,000) to four new research projects looking to …
First Human Embryonic Stem Cell Lines Approved for Use Under New NIH Guidelines
The National Institute of Health (NIH) announced the approval of the first 13 human embryonic stem cell (hESC) lines for…
Old Drug May Hold New Hope
A drug commonly used to treat non-Hodgkin's lymphoma and rheumatoid arthritis now also shows some promise in helping pat…
Success Rate of Islet Cells Transplants May Improve With New Treatment
TikoMed AB, a Swedish biotechnology company focused on development and commercialization of innovative treatments for im…